Hydromorphone
£43.00 – £425.00Price range: £43.00 through £425.00
Hydromorphone is a potent semi-synthetic opioid analgesic used for moderate-to-severe pain management. A valid doctor’s prescription is mandatory, and it is a controlled substance in the EU.
| Quantity |
2 MG Ć 99 ,4 MG Ć 100 ,5MG/5ML ,8 MG Ć 100 |
|---|
Buy Hydromorphone ā Medical Information Overview (EU Context)
Product Overview
Hydromorphone is a prescription-only strong opioid analgesic used for the management of severe pain. It is a semi-synthetic derivative of morphine and belongs to the WHO Step III category of opioid medicines.
Hydromorphone acts on the central nervous system by binding primarily to mu-opioid receptors, producing potent analgesic effects. Due to its high potency, it is reserved for situations where other pain treatments are not sufficient.
In European clinical practice, hydromorphone is strictly controlled and used only under specialist medical supervision because of its risks of respiratory depression, dependence, and misuse.
Clinical Uses
Hydromorphone may be used for:
- Severe acute pain requiring strong opioid therapy
- Cancer-related pain
- Palliative care and end-of-life symptom control
- Postoperative pain management in hospital settings
- Severe chronic pain in opioid-tolerant patients under specialist care
It is not indicated for mild or moderate pain conditions.
Mechanism of Action
Hydromorphone binds to mu-opioid receptors in the brain and spinal cord, resulting in:
- Reduced perception of pain
- Altered emotional response to pain
- Sedation and calming effects
- Dose-dependent respiratory depression
Its potency is significantly higher than morphine, requiring careful dose titration and monitoring.
Safety Information and Warnings
Hydromorphone must only be used under strict medical supervision.
Common risks and side effects include:
- Respiratory depression (potentially life-threatening)
- Drowsiness and sedation
- Nausea and vomiting
- Constipation (very common with opioids)
- Dizziness and impaired coordination
- Hypotension
Risk of severe adverse effects increases when combined with other central nervous system depressants.
Patients should avoid driving or operating machinery unless medically cleared.
Dependence, Tolerance, and Withdrawal
Hydromorphone has a high potential for:
- Physical dependence
- Psychological dependence
- Tolerance with ongoing use
Abrupt discontinuation may cause withdrawal symptoms such as:
- Anxiety and irritability
- Muscle aches and cramps
- Sweating and chills
- Insomnia
- Gastrointestinal distress
Any dose reduction should be gradual and medically supervised.
Drug Interactions
Hydromorphone may interact with:
- Alcohol (high risk of fatal respiratory depression)
- Benzodiazepines and sedatives (additive CNS depression)
- Other opioids (overdose risk)
- Antidepressants and other CNS-active medicines
Careful clinical supervision is required when used with interacting medications.
Contraindications and Precautions
Hydromorphone is not suitable for:
- Severe respiratory depression
- Acute severe asthma without monitoring
- Paralytic ileus
- Non-opioid-tolerant patients at high doses
- Known hypersensitivity to opioids
Extra caution is required in elderly, frail, or medically complex patients.
Overdose Risk
Hydromorphone overdose is a medical emergency and may present with:
- Severe respiratory depression
- Extreme sedation or unconsciousness
- Pinpoint pupils
- Loss of responsiveness
Immediate emergency treatment is required. Naloxone may be used in clinical settings to reverse opioid effects.
Special Populations
- Elderly patients: increased sensitivity to sedation and respiratory depression
- Pregnancy: use only if clearly necessary under medical supervision
- Breastfeeding: may pass into breast milk and affect the infant
Regulatory Note (EU Context)
Hydromorphone is a tightly controlled opioid in Europe and is restricted to hospital or specialist use. Its prescribing is closely regulated due to its potency and risk profile.
Conclusion
Hydromorphone is a strong opioid analgesic used for severe pain management in hospital and specialist care settings. It provides potent pain relief through mu-opioid receptor activation but carries significant risks, including respiratory depression, dependence, and overdose. It must only be used under strict medical supervision.
MAECENAS IACULIS
Vestibulum curae torquent diam diam commodo parturient penatibus nunc dui adipiscing convallis bulum parturient suspendisse parturient a.Parturient in parturient scelerisque nibh lectus quam a natoque adipiscing a vestibulum hendrerit et pharetra fames nunc natoque dui.
ADIPISCING CONVALLIS BULUM
- Vestibulum penatibus nunc dui adipiscing convallis bulum parturient suspendisse.
- Abitur parturient praesent lectus quam a natoque adipiscing a vestibulum hendre.
- Diam parturient dictumst parturient scelerisque nibh lectus.
Scelerisque adipiscing bibendum sem vestibulum et in a a a purus lectus faucibus lobortis tincidunt purus lectus nisl class eros.Condimentum a et ullamcorper dictumst mus et tristique elementum nam inceptos hac parturient scelerisqueĀ vestibulum amet elit ut volutpat.


Reviews
There are no reviews yet.